MedTrace Logo

Different Amoxicillin Treatment Regimens in Erythema Migrans Patients

NCT03966014 · Status: RECRUITING · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2026-03-25

No results posted yet for this study

Summary

The purpose of this study is to compare the efficacy of different amoxicilline treatment regimens in patients with erythema migrans.

Conditions

  • Erythema Migrans

Interventions

DRUG

EM-amoxicillin 3 x 10 days

Patients will receive amoxicillin 500 milligram tid for 10 days

DRUG

EM-amoxicillin 3 x 14 days

Patients will receive amoxicillin 500 milligram tid for 14 days

OTHER

Controls

No intervention.

Sponsors & Collaborators

  • University of Ljubljana School of Medicine, Slovenia

    collaborator OTHER

  • University Medical Centre Ljubljana

    lead OTHER

Principal Investigators

  • Daša Stupica, MD PhD · Department of Infectious Diseases, University Medical Centre Ljubljana, Slovenia

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-06-01
Primary Completion
2027-12-31
Completion
2027-12-31

Countries

  • Slovenia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03966014 on ClinicalTrials.gov